1Wagrowska-Danilewicz M,Danilewicz M.Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.Nefrologia,2007,27:710-715.
2Nielsen JS,McNagny KM.The role of podoealyxin in health and disease.J Am Soc Nephrol,2009,20:1669-1676.
3Patrakka J,Tryggvason K.New insights into the role of podocytes in proteinuria.Nat Rev Nephrol,2009,5:463-468.
4Patrakka J,Tryggvason K.Molecular make-up of the glomerular filtration barrier.Biochem Biophys Res Commun,2010,396:164-169.
5M(o)iller CC,Flesche J,Reiser J.Sensitizing the slit diaphragm with TRPC6 ion channels.J Am Soc Nephrol,2009,20:950-953.
6Dryer SE,Reiser J.TRPC6 channels and their binding partners in podocytes:role in glomerular filtration and pathophysiology.Am J Physiol Renal Physiol,2010,299:F689-F701.
7Kim EY,Suh JM,Chiu YH,et al.Regulation of podocyte BK (Ca) channels by synaptopodin,Rho,and actin microfilaments.Am J Physiol Renal Physiol,2010,299:F594-F604.
8Beck LH Jr,Salant DJ.Membranous nephropathy:recent travels and new roads ahead.Kidney Int,2010,77:765-770.
